Becker's Healthcare November 27, 2023
Ashleigh Hollowell

The Biden administration announced Nov. 27 that it plans to broaden the capabilities of the HHS to allow it to make further investments in domestic production of critical medicines and medical supplies.

The policy the administration is enacting falls under Title III of the Defense Production Act, which was enacted in 1950, during the Cold War, to bolster research, development, production and scaling of essential supplies. Invoking this policy allows for further investment to be...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Congress / White House, Govt Agencies, HHS, Supply Chain, Technology
Related Articles:
New Regulations Extend Health Coverage to Deferred Action for Childhood Arrivals (DACA) Recipients
New KFF Poll Finds that Many Older Voters Are Unaware of Medicare Drug Price Negotiation, But Awareness Has Grown
The Biden Administration’s Final Rule on Section 1557 Non-Discrimination Regulations Under the ACA
Senators take a step toward AI oversight
KFF Health Tracking Poll: The Public’s Views on the ACA - 2

Share This Article